4-cyclopentylamino-6-methyl-2-methylsulfanyl-pyrimidine-5-carbaldehyde | 1013101-76-2

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-cyclopentylamino-6-methyl-2-methylsulfanyl-pyrimidine-5-carbaldehyde
• 英文别名: 4-(cyclopentylamino)-6-methyl-2-methylsulfanylpyrimidine-5-carbaldehyde
• CAS: 1013101-76-2
• 化学式: C₁₂H₁₇N₃OS
• 分子量: 251.352
• InChiKey: NBGZPZRETZIOSW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  80.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-cyclopentylamino-6-methyl-2-methylsulfanyl-pyrimidine-5-carbaldehyde 、 丙二酸二乙酯 在 哌啶 、 溶剂黄146 作用下， 反应 72.0h， 以39.4%的产率得到8-cyclopentyl-4-methyl-2-methylsulfanyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid ethyl ester
  参考文献：
  名称：

  [EN] PYRIDO (2, 3-D) PYRIMIDIN0NE COMPOUNDS AND THEIR USE AS PI3 INHIBITORS
  [FR] COMPOSÉS DE PYRIDO (2, 3-D) PYRIMIDIN0NE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PI3

  摘要：

  公开号：

  WO2008032162A8

文献信息

• 4-METHYLPYRIDOPYRIMIDINONE COMPOUNDS
  申请人：Cheng Hengmiao

  公开号：US20080090801A1

  公开（公告）日：2008-04-17

  The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I), and to salts thereof, their synthesis, and their use as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα).

  本发明涉及一种新颖的4-甲基吡啶嘧啶酮化合物（I式），以及其盐、它们的合成和它们作为磷脂酰肌醇3-激酶α（PI3-Kα）抑制剂的用途。
• 4-methylpyridopyrimidinone compounds
  申请人：Pfizer Inc

  公开号：US08273755B2

  公开（公告）日：2012-09-25

  The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I), and to salts thereof, their synthesis, and their use as inhibitors of phosphoinositide 3-kinase alpha (PI3-Kα).

  本发明涉及一种新型的4-甲基吡啶嘧啶酮化合物（I）及其盐，其合成以及作为磷脂酰肌醇3-激酶α（PI3-Kα）抑制剂的用途。
• Bi-functional complexes and methods for making and using such complexes
  申请人：Gouliaev Alex Haahr

  公开号：US11225655B2

  公开（公告）日：2022-01-18

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.

  本发明涉及一种合成双功能复合物的方法，该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行，此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接，合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
• PYRIDO (2, 3-D) PYRIMIDIN0NE COMPOUNDS AND THEIR USE AS PI3 INHIBITORS
  申请人：Pfizer Products Incorporated

  公开号：EP2074122A1

  公开（公告）日：2009-07-01
• BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Nuevolution A/S

  公开号：EP2558577B1

  公开（公告）日：2018-12-12